Results 91 to 100 of about 87,718 (183)
D3Targets-2019-nCoV: A Web Server to Identify Potential Targets for Antivirals Against 2019-nCoV [PDF]
, 2020 2019-nCoV has caused more than 560 deaths as of 6 February 2020 worldwide, mostly in China. Although there are no effective drugs approved, many clinical trials are incoming or ongoing in China which utilize traditional chinese medicine or modern medicine.
Yulong Shi +8 more
openaire +1 more source
Rapid Response of an Academic Surgical Department to the COVID-19 Pandemic: Implications for Patients, Surgeons, and the Community. [PDF]
, 2020 BackgroundAs the coronavirus disease 2019 (COVID-19) pandemic continues to spread, swift actions and preparation are critical for ensuring the best outcomes for patients and providers.
Conte, Michael C +6 more
core
Influenza and Other Respiratory Viruses, Volume 20, Issue 2, February 2026.ABSTRACT Background Following WHO recommendations issued in 2019 and 2022, the National Influenza Center (NIC) of Côte d'Ivoire initiated the integration of Respiratory Syncytial Virus (RSV) and SARS‐CoV‐2 surveillance into its existing sentinel influenza surveillance to strengthen the monitoring of respiratory viruses.
Hervé A. Kadjo +13 more
wiley +1 more source
Physiological Reports, Volume 14, Issue 3, February 2026.Abstract Older adults are highly vulnerable to severe COVID‐19. Unlike our previous work on broad immunosenescence, this review focuses on peripheral hematological markers as practical indicators of risk. To examine lymphopenia, neutrophilia, and the neutrophil‐to‐lymphocyte ratio (NLR) as clinically accessible markers of immune aging and COVID‐19 ...
Maha Gasmi +4 more
wiley +1 more source
Role of the Eye in Transmitting Human Coronavirus: What We Know and What We Do Not Know
Frontiers in Public Health, 2020 The outbreak of the current 2019 novel coronavirus (2019-nCoV, now named SARS-CoV-2) infection has become a worldwide health threat. Currently, more information is needed so as to further understand the transmission and clinical characteristics of 2019 ...
Chuan-bin Sun +3 more
doaj +1 more source
Pangolin homology associated with 2019-nCoV [PDF]
, 2020 AbstractTo explore potential intermediate host of a novel coronavirus is vital to rapidly control continuous COVID-19 spread. We found genomic and evolutionary evidences of the occurrence of 2019-nCoV-like coronavirus (named as Pangolin-CoV) from dead Malayan Pangolins.
Zhang T, Wu Q, Zhang Z.
europepmc +2 more sources
Immunity, Inflammation and Disease, Volume 14, Issue 1, January 2026.In this study, we recruited a cohort of healthcare workers who were infected with Omicron BA.5 or received inhaled adenovirus vector vaccine to investigate the short‐term profile of antireceptor‐binding‐domain IgG antibody elicited by the virus or vaccine.
Zhaohui Luo +10 more
wiley +1 more source
The Appropriate Use of Testing for COVID-19 [PDF]
, 2020 Many public officials are calling for increased testing for the 2019 novel coronavirus disease (COVID-19), and some governments have taken extraordinary measures to increase the availability of testing.
Zitek, Tony
core
Structural Adaptability of IgA and IgM Supports Broad SARS‐CoV‐2 Variant Neutralization
Journal of Medical Virology, Volume 98, Issue 1, January 2026.ABSTRACT Neutralizing emerging SARS‐CoV‐2 variants requires antibodies effective not only against epitope mutations but also under variable antigenic presentations. We assessed the neutralization capacity of the same anti‐RBD monoclonal antibody (8A5) expressed as IgG, IgA, or IgM against 18 variants, identifying three neutralization classes: variants ...
Yalcin Pisil +6 more
wiley +1 more source
Wise Blood: The Principle of Overcoming in Disease and Immunity (Part 1) [PDF]
, 2020 The immune system is an intelligently made system designed for interaction with microbes even in a perfect world; it is more than a defense. However, in a post-fall world, it is primarily a body’s defense system.
Gillen, Alan L., Huy, Keoprommony
core +1 more source